Moderna Has Begun Seeking Full Approval For COVID-19 Vaccine

Killian Meara

Killian Meara, assistant editor for ContagionLive, joined the MJH Life Sciences team in November 2020. He graduated from William Paterson University with a degree in liberal studies, and concentrations in history and psychology. He enjoys film, reading, and pretending he is a good cook. Follow him on Twitter @krmeara or email him at [email protected]

Worries mount in Africa as only 2% of the population has received a vaccine.

Moderna recently announced that it has begun seeking full approval for its COVID-19 vaccine by the United States Food and Drug Administration (FDA) for individuals aged 18 years and older. The company has stated that it will be submitting trial data to the FDA on a rolling basis over the coming weeks. Moderna is seeking a priority review, which would give the FDA 6 months to take action on the approval. This comes after Pfizer announced last month that they have also begun the process of seeking full FDA approval for their COVID-19 vaccine.

Canada is set to receive 2.9 million doses of the Pfizer COVID-19 vaccine after the company announced they would increase their deliveries. For the month of May, Canada was receiving weekly deliveries of about 2 millions doses. Additional does of both Moderna and AstraZeneca vaccines are also expected, while expected doses of the Johnson and Johnson vaccine remain unclear. As of Sunday, Canada has reported 23 million doses administered, with around half of the population having received at least 1 shot.

After several issues have held up inoculation efforts in Venezuela, the campaign finally began again over this past weekend. To date, only around 1.1% of the population has received a dose of a COVID-19 vaccine. Around 1,000 people are expected to receive their first dose by end of day Monday.


661.47 million

45.96 per 100

United States

294.93 million

88.19 per 100


210.45 million

15.25 per 100


67.48 million

31.75 per 100

United Kingdom

64.92 million

95.63 per 100


49.94 million

59.61 per 100


36.22 million

53.61 per 100


34.95 million

57.81 per 100


28.5 million

19.53 per 100


27.05 million

9.89 per 100

Data Table per Our World in Data (May 30, 2021, 12 AM EST)

Despite a slowing in vaccination rates, the United States is slowly getting closer to President Bidens goal of having 70% of the adult population receive at least one dose of a COVID-19 vaccine by July fourth. As of Sunday, 62% of the adult population has gotten at least one shot and states all over the country are lifting their restrictions.



96.83 per 100



79.12 per 100

New York


100.78 per 100



87.08 per 100



98.20 per 100



91.85 per 100



84.59 per 100

New jersey


102.26 per 100



86.98 per 100



97.75 per 100

Data Table per CDC COVID-19 Tracker (May 30, 2021, 6 AM EST)

For more information on COVID-19 vaccination research, distribution, and assessment, check out some of these recent Contagion stories:

Pfizer-BioNTech COVID-19 Vaccine Achieves 100% Effectiveness in Adolescents

CDC Investigating Heart Inflammation in Teens Receiving COVID-19 Vaccine

FDA Issues EUA to Monoclonal Antibody for Treatment of COVID-19